Itron, Inc. (NASDAQ:ITRI) Given Consensus Rating of “Moderate Buy” by Brokerages

Itron, Inc. (NASDAQ:ITRI) has earned an average rating of “Moderate Buy” from the thirteen analysts that are presently covering the firm, Marketbeat reports. Five research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $104.18.

Several equities analysts have weighed in on the stock. Canaccord Genuity Group lifted their price target on shares of Itron from $105.00 to $115.00 and gave the company a “buy” rating in a report on Friday, May 3rd. Roth Mkm lifted their price target on shares of Itron from $102.00 to $112.00 and gave the company a “buy” rating in a report on Friday, May 3rd. TheStreet raised shares of Itron from a “c” rating to a “b-” rating in a report on Monday, February 26th. TD Cowen lifted their price objective on shares of Itron from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Friday, May 3rd. Finally, Oppenheimer lifted their price objective on shares of Itron from $100.00 to $110.00 and gave the company an “outperform” rating in a research report on Friday, May 3rd.

Itron Stock Performance

ITRI opened at $107.04 on Wednesday. The company has a current ratio of 1.90, a quick ratio of 1.40 and a debt-to-equity ratio of 0.33. The company has a market cap of $4.91 billion, a price-to-earnings ratio of 30.76, a PEG ratio of 1.07 and a beta of 1.38. The company’s 50 day moving average is $95.51 and its 200 day moving average is $81.83. Itron has a 12-month low of $56.11 and a 12-month high of $109.97.

Itron (NASDAQ:ITRI) last issued its quarterly earnings results on Thursday, May 2nd. The scientific and technical instruments company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.39. Itron had a net margin of 7.03% and a return on equity of 14.51%. The business had revenue of $603.44 million for the quarter, compared to the consensus estimate of $579.49 million. During the same quarter in the previous year, the firm earned $0.49 earnings per share. The company’s revenue for the quarter was up 22.0% on a year-over-year basis. On average, equities research analysts predict that Itron will post 3.9 EPS for the current year.

Insider Buying and Selling

In related news, SVP Christopher E. Ware sold 311 shares of the business’s stock in a transaction on Monday, May 13th. The shares were sold at an average price of $106.84, for a total value of $33,227.24. Following the sale, the senior vice president now owns 15,371 shares in the company, valued at $1,642,237.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Itron news, SVP Christopher E. Ware sold 311 shares of the business’s stock in a transaction on Monday, May 13th. The shares were sold at an average price of $106.84, for a total transaction of $33,227.24. Following the transaction, the senior vice president now owns 15,371 shares in the company, valued at $1,642,237.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Thomas Deitrich sold 3,362 shares of the business’s stock in a transaction on Monday, February 26th. The shares were sold at an average price of $87.10, for a total transaction of $292,830.20. Following the transaction, the chief executive officer now owns 205,162 shares in the company, valued at approximately $17,869,610.20. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 26,923 shares of company stock worth $2,495,196. Insiders own 1.45% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. GAMMA Investing LLC purchased a new stake in shares of Itron during the fourth quarter valued at $27,000. Contravisory Investment Management Inc. boosted its stake in shares of Itron by 61.5% during the first quarter. Contravisory Investment Management Inc. now owns 344 shares of the scientific and technical instruments company’s stock valued at $32,000 after purchasing an additional 131 shares during the period. Covestor Ltd boosted its stake in shares of Itron by 9,150.0% during the third quarter. Covestor Ltd now owns 555 shares of the scientific and technical instruments company’s stock valued at $34,000 after purchasing an additional 549 shares during the period. Harvest Fund Management Co. Ltd purchased a new stake in shares of Itron during the fourth quarter valued at $50,000. Finally, C M Bidwell & Associates Ltd. purchased a new stake in shares of Itron during the fourth quarter valued at $76,000. Institutional investors own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.